Cerebellum’s Zimmer Biomet ZBH Stock Holding History

Cerebellum’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$60K	Sell	452 -685	-60%	-$89.5K	0.28%	291
2020 Q2	$133K	Buy	+1,137	New	+$131K	0.09%	80
2019 Q4	$362K	Sell	2,493 -846	-25%	-$117K	0.19%	324
2019 Q3	$445K	Buy	3,339 +340	+11%	+$43.9K	0.29%	133
2019 Q2	$343K	Buy	2,999 +265	+10%	+$31K	0.28%	220
2019 Q1	$339K	Buy	2,734 +1,113	+69%	+$126K	0.29%	75
2018 Q4	$163K	Buy	+1,621	New	+$182K	0.11%	336
2018 Q2	–	Sell	-1,816	Closed	-$192K	–	541
2018 Q1	$192K	Buy	1,816 +679	+60%	+$78.9K	0.25%	81
2017 Q4	$133K	Buy	+1,137	New	+$129K	0.09%	80

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Cerebellum's ZBH Position: Q3 2020 in Review

Cerebellum reduced its Zimmer Biomet (ZBH) stake by 60% in Q3 2020, selling an estimated $89.5K and leaving 452 shares worth $60K. The position accounts for 0.28% of the portfolio, ranked #291.

Cerebellum first reported a position in ZBH in Q4 2017 and has held it in 9 quarters since. The position peaked at $445K in Q3 2019. 930 funds tracked by Wall St. Rank hold ZBH as of Q3 2020.

Cerebellum held 452 shares of Zimmer Biomet worth $60K as of Q3 2020.
Cerebellum sold 685 Zimmer Biomet shares in Q3 2020, an estimated $89.5K.
Zimmer Biomet made up 0.28% of Cerebellum's portfolio in Q3 2020, its #291 holding.
Cerebellum first reported a position in Zimmer Biomet in Q4 2017 and has held it in 9 quarters since.
Cerebellum's Zimmer Biomet position peaked at $445K in Q3 2019.
930 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.